Citation Explorer

MECOM (EVI1) Rearrangements: A Review and Case Report of Two MDS Patients with Complex 3q Inversion/Deletions.
Authors: Lawce, Helen and Szabo, Elina and Torimaru, Yumi and Davis, Craig and Osterberg, Karin and Olson, Susan and Moore, Steve
Journal: Journal of the Association of Genetic Technologists (2017): 9-14

Localization of a female-specific marker on the chromosomes of the brown seaweed Saccharina japonica using fluorescence in situ hybridization.
Authors: Liu, Yu and Bi, YanHui and Gu, JunGang and Li, LiHua and Zhou, ZhiGang
Journal: PloS one (2012): e48784

Application of tri-colour, dual fusion fluorescence in situ hybridization (FISH) system for the characterization of BCR-ABL1 fusion in chronic myelogenous leukaemia (CML) and residual disease monitoring.
Authors: Siu, Lisa Lp and Ma, Edmond Sk and Wong, Wai Shan and Chan, Man Hong and Wong, Kit Fai
Journal: BMC blood disorders (2009): 4

Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice.
Authors: Rojo, Marcial García and Bueno, Gloria and Slodkowska, Janina
Journal: Folia histochemica et cytobiologica (2009): 349-54

Comparison of quantitative immunofluorescence with conventional methods for HER2/neu testing with respect to response to trastuzumab therapy in metastatic breast cancer.
Authors: Giltnane, Jennifer M and Molinaro, Annette and Cheng, Huan and Robinson, Andrew and Turbin, Dmitry and Gelmon, Karen and Huntsman, David and Rimm, David L
Journal: Archives of pathology & laboratory medicine (2008): 1635-47

Bladder cancer detection using FISH (UroVysion assay).
Authors: Halling, Kevin C and Kipp, Benjamin R
Journal: Advances in anatomic pathology (2008): 279-86

AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray.
Authors: Giltnane, J M and Murren, J R and Rimm, D L and King, B L
Journal: Histopathology (2006): 161-9

A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia.
Authors: Smoley, Stephanie A and Brockman, Stephanie R and Paternoster, Sarah F and Meyer, Reid G and Dewald, Gordon W
Journal: Cancer genetics and cytogenetics (2004): 1-6